FDA Office of Acq Grant Svcs of Food and Drug Administration posted this Special Notice on Oct 30, 2026. Responses are due Jan 22, 2027. NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)), product or service code AJ11 (General Science/Technology - Physical Sciences - Mathematics/Statistics (R&D)). Solicitation number FDABAA-27-00123.
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm.
Updated the Special Notice Archive date from 15 days after response date to 09/30/27.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Sign up free to download these 4 files.
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science - Food and Drug Administration
Full details, the documents and the posting link, plus saved bids and daily alerts for your team.
7 days free, no credit card. Already have an account? Log in
